The process of obtaining a reference drug or comparator drug product for use in a clinical trial is referred to as comparator sourcing for clinical trials. A comparator drug is often required as a control/ reference treatment group in clinical trials to examine the safety and efficacy of the…

A patent is an intellectual property that protects inventions from copying and reproducing by any other entity.  It grants the patent holder the exclusive right of about 20 years to prevent others from making, using, selling, or importing the invention without their permission. In order to qualify any invention to be patentable, it must meet…

Why Comparator Sourcing Matters In today’s clinical research environment, comparator sourcing has evolved into a strategic function. Selecting the right comparator impacts not only regulatory approvals but also patient safety and trial timelines. As clinical trials become increasingly global, choosing and procuring appropriate comparators—whether for oncology, rare diseases, or chronic conditions—requires deep planning and expertise.…

Comparator drug sourcing refers to the process of acquiring the comparator drug for use in clinical trials The sourcing process involves identifying a suitable comparator drug, negotiating with suppliers, ensuring regulatory compliance, and managing the logistics of delivery and distribution. A comparator drug is a medication used as a standard or control in a clinical…